TabsDetailsBasic DetailsDate Posted: Thursday, February 1, 2018Status: CompleteMedical Product: CYP inducer, CYP inhibitor, oxycodone, oxymorphoneDescription: The goal of this query was to estimate the proportion of incident oxycodone and oxymorphone users concomitantly using a selection of cytochrome P450 (CYP) enzyme inhibitors and inducers in the Sentinel Distributed Database (SDD). Data from January 1, 2013 to December 31, 2016 from 16 health plans contributing to the SDD were included in this report. This request was distributed on June 2, 2017. Read More Deliverables (1)Sentinel Modular Program Report: Concomitant Use of Opioid Analgesics and Cytochrome P450 (CYP) Inhibitors and InducersAdditional InformationAdditional DetailsFDA Center: CDERTime Period: January 1, 2013 - December 31, 2016Study Type: Modular ProgramAssessment Type: Safety AnalysesPopulation / Cohort: All individualsData Sources: Sentinel Distributed Database (SDD)Related Links: Concomitant Filled Prescriptions of Oxymorphone or Oxycodone with CYP3A Inhibitors and Inducers
